Geovax Labs Inc (GOVX)

03:06 AM

D. Boral Capital Cuts GeoVax Labs (NASDAQ:GOVX) Price Target to $9.00 - Defense World

03:06 AM

02:26 AM

GeoVax Labs, Inc. (NASDAQ:GOVX) Given Consensus Recommendation of “Buy” by Analysts - Defense World

02:26 AM

May 04, 2025

Geode Capital Management LLC Has $223,000 Holdings in GeoVax Labs, Inc. (NASDAQ:GOVX) - Defense World

May 04, 2025

May 03, 2025

Geovax highlights progress on mpox vaccine and COVID-19 trial advancements - MSN

May 03, 2025

May 02, 2025

GeoVax Labs Earnings Call: Mixed Sentiment and Future Prospects - TipRanks

May 02, 2025

May 02, 2025

Geovax Labs (GOVX) Faces Price Target Reduction by Analyst | GOV - GuruFocus

May 02, 2025

May 02, 2025

Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

May 02, 2025

May 02, 2025

GeoVax Labs Reports Q1 2025 Progress Amid Challenges - TipRanks

May 02, 2025

May 01, 2025

Earnings call transcript: GeoVax Q1 2025 reveals revenue from BARDA contract - Investing.com

May 01, 2025

May 01, 2025

GeoVax Labs Q1 2025 Earnings Call Transcript - MarketBeat

May 01, 2025

Apr 28, 2025

Geovax Labs is a buy, Roth says - Cantech Letter

Apr 28, 2025

Apr 27, 2025

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia - ADVFN

Apr 27, 2025

Apr 25, 2025

GOVX’s 2023 Market Dance: Down -59.51% – Time to Invest? - investchronicle.com

Apr 25, 2025

Apr 25, 2025

Geovax Labs Inc (GOVX) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com

Apr 25, 2025

Apr 24, 2025

GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater - Yahoo Finance

Apr 24, 2025

Apr 24, 2025

GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress - Yahoo Finance

Apr 24, 2025

Apr 23, 2025

GeoVax to Host Q1 2025 Financial Results Conference Call, Spotlight COVID-19 Vaccine and Cancer Therapy Progress - citybuzz -

Apr 23, 2025

Apr 23, 2025

GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025 - The Globe and Mail

Apr 23, 2025

Apr 22, 2025

GeoVax Bolsters Technical Development with Seasoned Biologics Executive - citybuzz -

Apr 22, 2025

Apr 22, 2025

GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations - The Globe and Mail

Apr 22, 2025

Apr 20, 2025

Analysts Issue Forecasts for GeoVax Labs FY2029 Earnings - Defense World

Apr 20, 2025

Apr 19, 2025

HC Wainwright Estimates GeoVax Labs FY2025 Earnings - Defense World

Apr 19, 2025

Apr 18, 2025

Alliance Global Partners Cuts GeoVax Labs (NASDAQ:GOVX) Price Target to $8.50 - Defense World

Apr 18, 2025

Apr 18, 2025

HC Wainwright Reiterates Buy Rating for GeoVax Labs (NASDAQ:GOVX) - Defense World

Apr 18, 2025

Apr 18, 2025

Q2 EPS Estimates for GeoVax Labs Lowered by Noble Financial - Defense World

Apr 18, 2025

Apr 16, 2025

GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

GeoVax Labs price target lowered to $14 from $18 at D. Boral Capital - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum - Yahoo Finance

Apr 16, 2025

Apr 15, 2025

Geovax Labs stock hits 52-week low at $0.78 amid market challenges By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Top Midday Decliners - marketscreener.com

Apr 15, 2025

Apr 15, 2025

These Numbers Reveal How Powerful Geovax Labs Inc (NASDAQ: GOVX) Stock Is - stocksregister.com

Apr 15, 2025

Apr 15, 2025

GeoVax Labs (GOVX) Faces Setback with Price Target Reduced by Ro - GuruFocus

Apr 15, 2025

Apr 15, 2025

GeoVax Labs (GOVX) Faces Setback with Price Target Reduced by Roth Capital | GOVX Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

GeoVax to Present at the Emerging Growth Conference on April 16, 2025 - Yahoo Finance

Apr 15, 2025

Apr 15, 2025

GeoVax (GOVX) Faces Setback with Termination of COVID-19 Vaccine Project | GOVX Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall - marketscreener.com

Apr 15, 2025

Apr 15, 2025

GeoVax Labs (GOVX) Faces Setback as BARDA-Funded Trial Ends | GO - GuruFocus

Apr 15, 2025

Apr 15, 2025

Geovax Labs stock hits 52-week low at $0.78 amid market challenges - Investing.com Canada

Apr 15, 2025

Apr 15, 2025

GeoVax to Present Clinical Data at Upcoming April Industry Events - Yahoo Finance

Apr 15, 2025

Apr 15, 2025

GeoVax Labs (GOVX): Price Target Lowered Amid BARDA Project Pause | GOVX Stock News - GuruFocus

Apr 15, 2025

Apr 14, 2025

GeoVax Labs contract with BARDA terminated By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

GeoVax Labs Got Written Notification From Advanced Technology International - MarketScreener

Apr 14, 2025

Apr 14, 2025

GeoVax tumbles as HHS ends mid-stage COVID vaccine trial - TradingView

Apr 14, 2025

Apr 14, 2025

GeoVax Labs contract with BARDA terminated - Investing.com

Apr 14, 2025

Apr 12, 2025

Geovax labs director John Spencer buys $9,800 in stock - Investing.com Australia

Apr 12, 2025

Apr 12, 2025

GeoVax Labs (NASDAQ:GOVX) Earns “Buy” Rating from D. Boral Capital - Defense World

Apr 12, 2025

Apr 11, 2025

Geovax labs director John Spencer buys $9,800 in stock By Investing.com - Investing.com Canada

Apr 11, 2025

Apr 10, 2025

Geovax labs VP John Sharkey acquires $5,940 in common stock By Investing.com - Investing.com Canada

Apr 10, 2025

Apr 10, 2025

GeoVax Labs (GOVX) Gains Favor with BARDA Contract Amid FDA Vacc - GuruFocus

Apr 10, 2025

Apr 10, 2025

Geovax labs VP John Sharkey acquires $5,940 in common stock - Investing.com Australia

Apr 10, 2025

Apr 10, 2025

GeoVax Labs, Inc. (NASDAQ:GOVX) Given Average Recommendation of “Buy” by Analysts - Defense World

Apr 10, 2025

Apr 09, 2025

GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent - Yahoo Finance

Apr 09, 2025

Apr 07, 2025

Geovax Labs stock hits 52-week low at $0.95 amid challenges - Investing.com Australia

Apr 07, 2025